
TL;DR: A 2026 longitudinal analysis in the Journal of Affective Disorders tracked 635 older adults with new-onset loneliness and found that cognitive decline matched controls before loneliness began, then accelerated after onset, especially when loneliness per…
Read article ↗
TL;DR: A 2026 preprint on medRxiv using the Harvard Biomarkers Study found that 43% of Parkinson’s disease patients had depression, anxiety, sleep apnea, or restless legs syndrome, compared with 21% of controls. Key Findings 1,224-person cohort: Researchers an…
Read article ↗
TL;DR: A 2026 medRxiv preprint applied the AT(N) framework, an Alzheimer’s disease biomarker system for amyloid, tau, and neurodegeneration, to 84 older adults with focal epilepsy and found that only 32.1% had normal blood biomarkers, while early-onset epileps…
Read article ↗
TL;DR: A 2026 study in Microbiome found that in older adults at metabolic risk, virgin olive oil was linked to better cognitive preservation and richer gut microbiota, while common refined olive oil pointed the other way. Key Findings Metabolic-risk cohort tra…
Read article ↗
TL;DR: A 2026 study in Cell Chemical Biology found that alzheimer’s inflammation may be driven by a specific chemical switch: S-nitrosylation of STING at cysteine 148, which pushed innate immune signaling toward synaptic damage. Key Findings STING carried the…
Read article ↗
TL;DR: A 2026 study in Neurology Open Access found that in 793 dementia-free adults, higher vitamin D levels around age 39 were associated with less tau readout on PET brain imaging about 16 years later, while amyloid beta did not show the same relationship. K…
Read article ↗
TL;DR: A 2026 study in Translational Psychiatry found that three different plasma p-tau217 assays separated Alzheimer’s dementia from controls and frontotemporal degeneration with excellent accuracy, shifting the test from whether the marker works to which pla…
Read article ↗
TL;DR: A 2026 review in Reviews in the Neurosciences argues that chemotherapy-induced peripheral neurotoxicity (CIPN), nerve injury from cancer treatment, can involve central nervous system changes that help explain chronic neuropathic pain and chemotherapy-re…
Read article ↗
TL;DR: A 2026 Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring study found that orbitofrontal and frontoinsular visual rating scales on MRI helped distinguish possible from probable behavioral variant frontotemporal dementia. Key Findings bvF…
Read article ↗
TL;DR: A 2026 study in Nature Communications found that self-administered finger-prick blood tests for phosphorylated tau 217 (p-tau217), an Alzheimer’s tau marker, and glial fibrillary acidic protein (GFAP), an astrocyte-injury marker, correlated with cogniti…
Read article ↗